Klein Michael Frederick 4
4 · TRAVELERS COMPANIES, INC. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
Travelers (TRV) EVP Michael Klein Exercises Options, Sells Shares
What Happened
Michael F. Klein, Executive Vice President and President, Personal Insurance at Travelers (TRV), reported same-day option exercises and an open-market sale on 2026-02-06. He exercised options to acquire 10,000 shares at $132.58 each (cost ~$1,325,800) and sold 10,000 shares in the open market at a weighted average price of $301.18 (proceeds ~$3,011,783). The filing also shows a separate derivative conversion entry for 10,000 shares reported as disposed at $0.
Key Details
- Transaction date: 2026-02-06 (reported on Form 4 filed 2026-02-09).
- Exercise: 10,000 shares @ $132.58 = $1,325,800 (code M — option exercise/conversion).
- Sale: 10,000 shares @ weighted avg $301.18 = $3,011,783 (code S — open-market sale). Footnote F1: the $301.18 is a weighted average across prices $300.67–$301.42; the filer can provide a breakdown on request.
- Additional derivative line: 10,000 shares listed as exercised/converted and disposed @ $0 (reported as code M with zero proceeds); the filing does not further explain this entry.
- Shares owned after the transactions: not specified in the provided filing.
- Filing lag: transactions dated Feb 6 were reported on Feb 9 (three days later); investors may want to confirm timeliness relative to the 2-business-day Form 4 rule.
Context
Because the exercise and sale occurred the same day, this appears to be a cashless-type outcome where options were exercised and shares were immediately sold (common for covering exercise costs, taxes, or realizing gains). Sales by executives are often routine and do not, by themselves, signal a change in opinion about the company. The unexplained zero-proceeds derivative line should be interpreted cautiously—the filing’s footnote or additional disclosures may clarify if it reflects a net settlement, option cancellation, or reporting detail.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-06$132.58/sh+10,000$1,325,800→ 43,638.031 total - Sale
Common Stock
[F1]2026-02-06$301.18/sh−10,000$3,011,783→ 33,638.031 total - Exercise/Conversion
Stock Options (Right to Buy)
2026-02-06−10,000→ 20,000 totalExercise: $132.58From: 2023-02-04Exp: 2030-02-04→ Common Stock (10,000 underlying)
- 1,881.671(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents the weighted average sales price for price increments ranging from $300.67 to $301.42. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.